3+、CD4+、CD4+/CD8+均顯著高于對(duì)照組(P<0.05)。研究組治療后D-dimer、APACHEⅡ評(píng)分均顯著低于對(duì)照組水平(P<0.05);研究組7 d內(nèi)MODS發(fā)生率(13.3% vs 20.0%)與病死率(10.7% vs 13.3%)低于對(duì)照組,但差異均無(wú)統(tǒng)計(jì)學(xué)意義。結(jié)論 烏司他丁治療重癥膿毒癥基礎(chǔ)上聯(lián)合使用血必凈注射液能進(jìn)一步抑制炎癥反應(yīng),調(diào)節(jié)細(xì)胞免疫功能,減輕高凝狀態(tài)。;Objective To observe the influences of Xuebijing injection combined with UTI on variations of serum factor, T cell subsets and D-dimer for severe sepsis patients. Methods 150 severe sepsis patients from January 2014 to March 2016 were selected and randomly divided into study group and control group, each with 75 cases, based on conventional therapy control group added with UTI injection for 7d,observation group jointly added with Xuebijing injection, variations of inflammatory factor, T cell subsets and D - dimer levels before and 7d after treatment were noted,and MODS incidence and 7 d mortality ratio of the two groups were compared. Results The study group after treatment with TNF-α, IL-6, CRP, PCT were significantly lower than the control group (P<0.05). CD3+, CD4+, CD4+/CD8+ of study group after treatment were significantly higher than the control group (P<0.05). D-dimer and APACHEⅡ score of study group after treatment were significantly lower than the control group (P<0.05). MODS incidence rate (13.3% vs.20.0%) and mortality ratio (10.7% vs.13.3%) of study group within 7d were both lower than the control group, but the difference were not significant. Conclusion Based on UTI treatment for severe sepsis, Xuebijing injection added can further suppress inflammatory response, regulate cell immune function, alleviate the hypercoagulable state."/>